Catheters Market Research Report by Lumen, Product, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

The Global Catheters Market size was estimated at USD 48.44 billion in 2021 and expected to reach USD 51.96 billion in 2022, and is projected to grow at a CAGR 7.44% to reach USD 74.54 billion by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Catheters to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Lumen, the market was studied across Double-lumen, Single-lumen, and Triple-lumen.

Based on Product, the market was studied across Cardiovascular, Intravenous, Neurovascular, and Urology. The Cardiovascular is further studied across Electrophysiology Catheters, IVUS Catheters, PTA Balloon Catheters, and PTCA Balloon Catheters. The Intravenous is further studied across Central Venous Catheters, Midline Peripheral Catheters, and Peripheral Catheters. The Urology is further studied across External Catheters, Foley Catheters, Hemodialysis Catheters, Intermittent Catheters, and Peritoneal Catheters.

Based on End User, the market was studied across Hospital Stores and Retail Stores.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Catheters market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Catheters Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Catheters Market, including Abbott Laboratories, Access Vascular, Inc., Alvimedica, AMG International GmbH, Amsino International, Inc., B. Braun Melsungen AG, Becton, Dickinson, and Company, Boston Scientific Corporation, Coloplast Group, ConvaTec Group PLC, Cook Medical Incorporated, Cure Medical LLC, Edwards Lifesciences Corporation, Hollister Incorporated, Johnson & Johnson Services Inc, Medinol Ltd, Medtronic PLC, Merit Medical Systems, RIST Neurovascular, Inc, Simeks Tibbi Ürünler, Smith Medical Inc., Stryker Corporation, Teleflex Incorporated, and Terumo Corporation.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Catheters Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Catheters Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Catheters Market?
4. What is the competitive strategic window for opportunities in the Global Catheters Market?
5. What are the technology trends and regulatory frameworks in the Global Catheters Market?
6. What is the market share of the leading vendors in the Global Catheters Market?
7. What modes and strategic moves are considered suitable for entering the Global Catheters Market?

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing incidence of chronic diseases among the population globally
5.1.1.2. Rising preference for minimally invasive procedures
5.1.1.3. Increasing geriatric population with incontinence problems
5.1.2. Restraints
5.1.2.1. Concerns over infections and other complications
5.1.3. Opportunities
5.1.3.1. Proliferation in the favorable government funding for research and development activities
5.1.3.2. Emerging number of midscale catheter manufacturers
5.1.4. Challenges
5.1.4.1. Rise in the number of product recalls and failures
5.1.4.2. Issues pertinent with trade barriers and taxation
5.2. Cumulative Impact of COVID-19

6. Catheters Market, by Lumen
6.1. Introduction
6.2. Double-lumen
6.3. Single-lumen
6.4. Triple-lumen

7. Catheters Market, by Product
7.1. Introduction
7.2. Cardiovascular
7.3.1. Electrophysiology Catheters
7.3.2. IVUS Catheters
7.3.3. PTA Balloon Catheters
7.3.4. PTCA Balloon Catheters
7.3. Intravenous
7.4.1. Central Venous Catheters
7.4.2. Midline Peripheral Catheters
7.4.3. Peripheral Catheters
7.4. Neurovascular
7.5. Urology
7.6.1. External Catheters
7.6.2. Foley Catheters
7.6.3. Hemodialysis Catheters
7.6.4. Intermittent Catheters
7.6.5. Peritoneal Catheters

8. Catheters Market, by End User
8.1. Introduction
8.2. Hospital Stores
8.3. Retail Stores

9. Americas Catheters Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Catheters Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Catheters Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Abbott Laboratories
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Access Vascular, Inc.
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Alvimedica
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. AMG International GmbH
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Amsino International, Inc.
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. B. Braun Melsungen AG
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Becton, Dickinson, and Company
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Boston Scientific Corporation
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Coloplast Group
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. ConvaTec Group PLC
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Cook Medical Incorporated
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Cure Medical LLC
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Edwards Lifesciences Corporation
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Hollister Incorporated
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Johnson & Johnson Services Inc
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. Medinol Ltd
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. Medtronic PLC
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. Merit Medical Systems
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. RIST Neurovascular, Inc
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. Simeks Tibbi Ürünler
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services
13.21. Smith Medical Inc.
13.21.1. Business Overview
13.21.2. Key Executives
13.21.3. Product & Services
13.22. Stryker Corporation
13.22.1. Business Overview
13.22.2. Key Executives
13.22.3. Product & Services
13.23. Teleflex Incorporated
13.23.1. Business Overview
13.23.2. Key Executives
13.23.3. Product & Services
13.24. Terumo Corporation
13.24.1. Business Overview
13.24.2. Key Executives
13.24.3. Product & Services

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing